Jonathan Barratt, MD, consultant nephrologist and professor of renal medicine, University of Leicester and John Walls Renal Unit, Leicester, provides a comprehensive overview of IgA nephropathy. Professor Barratt also discusses updates on new treatments for patients with IgA nephropathy.
This video discusses IgA nephropathy (IgAN), a kidney disease where proteins from the immune system build up in the kidney filters, causing inflammation and potential damage. It details…
Jennifer Vaughan, APRN, and Kenneth K. Afenya, MD, of Lex Kidney Care, Lexington, Kentucky, discuss the basics of IgA nephropathy, including signs and symptoms, as well as epidemiology…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
In this heartfelt video, four different patients share their journies with IgA nephropathy, kidney failure, and the eventual need for a transplant. Initially unaware of their conditions, they…
Dana V. Rizk, MD, professor of medicine, University of Alabama at Birmingham; and Gerald Appel, MD, professor of medicine and co-director of the Center for Glomerular Disease, Columbia…
Professor Jonathan Barratt, head of the Renal Research Group within the College of Life Sciences at the University of Leicester, discusses the latest advancements in the treatment of…
Explore the early stages of IgA nephropathy, a kidney disease that often goes unnoticed until lab tests reveal abnormalities like protein or red blood cells in urine, or…
From different backgrounds and lifestyles, Elle, Jennifer, Tony, and Sean discuss their first-hand experiences with IgA nephropathy and the associated challenges of living with this rare disease.
Dawn J. Caster, MD, FASN, associate professor of medicine, Division of Nephrology & Hypertension, University of Louisville School of Medicine, Louisville, Kentucky, discusses IgA nephropathy, including when to…
Jonathan Barratt, MD, University of Leicester, UK, discusses the need for improved continuity of care for patients with IgA nephropathy. Professor Barratt notes that the rarity of the…
